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Abstract
Chronic pain is increasingly prevalent and costly and will continue to be with the
increasing mean age of America’s population. It is important to identify
interventions addressing pain-related biopsychosocial aspects. The purpose of
the current study was to examine if a single session of specific neurofeedback
(NF) protocols had an effect on subjective fear and physiological fear-avoidance
behaviors in relation to pain-related stimuli. Correlational analyses revealed that
FPQ-III minor pain scores were negatively associated with total fixation duration
while looking at pain-related pictures. One-way ANOVAs revealed differences
approaching significance for those trained on Left-Hemisphere NF protocols
compared to those in Sham training for total fixation duration, moderate effect
sizes were found. Statistically significant group differences were found for those
trained on Right-Hemisphere protocols compared to those trained on LeftHemisphere protocols for first fixation durations. Findings support research that
implicates NF training as a neuromodulation technique for the subjective pain
experience.
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Introduction
Effects of One Neurofeedback Session on Relationship between Fear-Of-Pain
and Visual Avoidance of Pain
Chronic pain is an extremely prevalent condition. It is estimated that 70
million Americans experience some form of acute, recurrent, or chronic pain
each year and that 10 percent of the population report the presence of pain at
least 100 days a year (Cassidy, Cote, Carroll, & Kristman, 2005; Covington,
2007). Chronic pain has been revealed to affect healthy, college aged students
as well. Hastie, Riley, and Fillingim (2005) found a prevalence rate for painful
experiences at 50% for their college-aged sample. Hastie et al. (2005) also
found that the proportion of participants reporting painful experiences was
comparable across three ethnic groups including African American, Hispanic,
and Caucasian. Kennedy, Kassab, Gilkey, Linnel, and Morris (2008) found
similar results with an annual prevalence rate of 42.8% for lower back pain in
college students from a major university in Colorado.
Chronic pain complaints result in millions of physician office visits per year
(Hing, Cherry & Woodwell, 2006), and as many as 150 million lost work days
(Guo, Tanaka, Halperin, & Cameron, 1999). Chronic pain treatments often
involve increasing doses of a variety of medications to gain a measure of relief.
Unfortunately, these current pharmacological treatments are moderately effective
1

at best (Turk, Wilson, & Cahana, 2011), and often carry important side effects
(Noble et al., 2007; Van Tulder, Scholten, Koes, & Deyo, 2000; Verdu,
Decosterd, Buclin, Stiefel, & Berney, 2008). As a result, multiple treatment
alternatives have been proposed. The Purpose of the current study was to
explore one of these alternative treatment options, specifically Neurofeedback.
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CHAPTER I
Pain
Johannes, Le, Zhou, Johnston, and Dworkin (2010) found a prevalence
rate of 30% for chronic pain in a nationally representative sample. Half of those
who reported having chronic pain also reported daily pain, and average pain
intensity for the past three months as greater than or equal to 7 on a scale from 1
to 10. According to Gaskin and Richard (2012), the total annual cost of pain in
2010 was $560 to $635 billion with additional health care costs due to pain
ranging from $261 to $300 billion. Pain also represents a significant loss in
productivity in the workforce ranging from $299 to $335 billion annually (Gaskin &
Richard, 2012). Chronic pain is an increasingly prevalent and costly condition
and this trend will continue upward with the ever-increasing average age of
America’s population (Fredburger et al., 2009)
Pain has been defined as “an unpleasant sensory and emotional
experience associated with actual or potential tissue damage, described in terms
of such damage” (Merskey & Bogduk, 1994, p. 212). The function of pain, as an
aversive experience, can be conceptualized as adaptive and/or protective in
nature (Asmundson, Parkerson, & D’Ambrosio, 2015). In other words, the pain
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sensation often draws the attention of the individual to potentially damaging
stimuli within their environment. From a learning perspective, pain experiences
facilitate discrimination and avoidance of any stimulus that may be dangerous to
the individual or hinder their ability to heal from previous injury. Therefore, pain
perception involves not only physiological components but also cognitive and
emotional components.
Pain is often differentiated based on the duration of the experience: as
acute or chronic. Acute pain is the sensation that comes from activation of
specialized pain receptors (nociceptors) for a limited time and may or may not be
associated with significant tissue damage (Dafny, 1997). Loeser and Melzack
(1999) described acute pain in relation to the activation of nociceptors at the site
of local tissue damage as well. In specific, Authors explain that an injury
modifies characteristics of the pain receptors, their connections to the central
nervous system, and the autonomic nervous system within that body region to
produce an acute pain sensation. Typically, pain report subsides before the
organic pathology is eventually resolved. The direct relation to actual tissue
damage, and the limited nature of the pain perception and healing process make
acute pain inherently different from other types of pain, specifically chronic pain
(Dafny, 1997; Loeser & Melzack, 1999).
Pain is characterized as chronic when it is present on the individual for at
least three months (Gatchel et al., 2007). Chronic pain is also often linked to an
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inability of the organism to adapt or protect from actual or potential damage
(Asmundson et al., 2015). Chronic spine pain, especially, has a high impact on
the sufferer’s everyday functioning, as a range of their activities are often
severely limited, leading to difficulties with daily chores, social life, and work
(Aronoff, 1991; Faucett & McCarthy, 2003; Nurmikko, Nash, & Wiles, 1998).
Persistent or long-term pain can lead to increased irritability and impatience,
which could heighten reactivity to daily life stressors (Asmundson et al., 2015).
Considering this increased reactivity to stressors, those suffering from chronic
pain tend to develop depression-like symptoms: difficulties with concentration,
lack of interpersonal interaction, increased fatigue, and isolation (Basbaum,
Bautista, Scherrer, & Julius, 2009; Basbaum & Woolf, 1999; Burkey, 2014;
Dafny, 1997). Subsequently, the peripheral and central nervous systems attempt
adapt to constant state of stress resulting in an anticipation of future pain-related
events (Dafny, 1997). Together, these symptoms make it difficult for those
suffering from chronic pain to process future pain in a healthy way (Amtmann et
al., 2015). In fact, some researchers have found that chronic pain sufferers are
at a higher risk for developing psychopathologies (Dersh, Gatchel, Polatin, &
Mayer, 2002).

5

Chapter II
Biological Mechanisms of Pain
Pain perception starts with a physical process that affect specialized nerve
fibers, which in turn signal the central nervous system that a painful event has
occurred (i.e. nociception; Julius & Basbaum, 2001). Nociception is a group of
biological processes in response to noxious stimuli and this can be measured
objectively for every individual (Burkey, 2014). For nociception to become
painful, there must be awareness of the elicited stimulus (Julius & Basbaum,
2001). Therefore, pain by definition, is affected by not only biological but also
psychological processes (Gatchel, 2005). In fact, the pain experience depends
on variables within everyone, which leads to pain being subjective in nature (i.e.,
each person experiences pain in a unique way) (Gatchel et al., 2007). The next
sections describe the process of nociception:
Nociception
Peripheral. The process of nociception starts at the receptor site (or the
specialized fibers that receive information) usually localized within the peripheral
nervous system. The peripheral pathway of pain perception relies heavily on
information transmitted from nociceptors, which fall within three distinct groups
(Burkey, 2014; Dafny, 1997). The largest group of nociceptors, called C-fibers,
conduct slowly due to unmyelinated axons, and typically respond to thermal,
6

mechanical, or chemical noxious stimuli (Burkey, 2014; Dafny, 1997). The
second group of nociceptors, called A-delta fibers, conduct more rapidly because
of their myelinated axons (Burkey, 2014; Dafny, 1997). These nociceptors are
responsible for fast or sharp pain sensations. The final category of nociceptors,
referred to as sleeping or silent nociceptors, typically respond only to noxious
stimuli that falls within extreme ranges of intensity (Burkey, 2014; Dafny, 1997).
Activation of any of these categories of nociceptors is unpleasant and can
produce pain (Burkey, 2014; Dafny, 1997). Continuous or persistent activation of
nociceptors could cause sensitization (lowering the threshold for activation),
which could allow for normally inoffensive stimuli to provoke noxious sensations
(Basbaum et al., 2009; Basbaum & Woolf, 1999).
Central. After activation of peripheral nerve tissue, the afferent
nociceptive information enters the spinal cord and then the brain. Afferent spinal
pathways include the spinothalamic, spinoparabrachio–amygdaloid and
spinoreticulo–thalamic pathways (Dafny, 1997). (See Figure 1. Afferent Spinal
Pathways). At the brain level, nociceptive information from the thalamus is
projected to the insula, anterior cingulate cortex (ACC), primary somatosensory
cortex (S1) and secondary somatosensory cortex (S2), and the Prefrontal Cortex
(PFC), whereas information from the amygdala (AMY) is projected to the basal
ganglia (BG) (Burkey, 2014). In addition, studies have found a correlation with
observed lesions on the parietal lobe, and pain perception. A study by
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Greenspan et al. (1999) demonstrated that the posterior parietal area (i.e.,
parietal operculum) is important for nociceptive input (as measured by evoked
potentials, MEG, PET and fMRI) associated with painful stimuli. Each one of
these different neural pathways plays an important part in the experience of pain
(Burkey, 2014).

Figure 1. Afferent spinal pathways.
Interpretative studies of these pathways have demonstrated some links
between these systems and its functionality. For instance, the somatosensory
cortices (S1 and S2) encode sensory information from noxious stimuli, including
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the location and duration of pain (Burkey, 2014). On the other hand, the insula
and ACC, most often considered part of the limbic system, are crucial for
encoding the emotional and motivational (i.e., fight, flight, and freeze)
components of a painful experience (Lenz, Casey, Jones, & Willis, 2009).
Interestingly, researchers have revealed that associated pain-brain
pathways can be activated without experiencing noxious stimuli (Lenz et al.,
2009). For example, studies have shown that simply observing another person
in pain may activate some of these pain-associated brain pathways and this is
especially the case when the individual is observing a loved one in pain rather
than a stranger (Burkey, 2014). This activation of pain-brain pathways without
any actual nociception could act as a priming mechanism for the brain, which
could lead to an enhanced pain experience (Basbaum et al., 2009; Basbaum &
Woolf, 1999)
Overall, pain is a subjective experience that may serve a protective
function under specific circumstances. In specific, acute pain sensations bring
awareness to injury and possible tissue damage leading to the pursuit of medical
attention. However, pain that is persistent or recurrent for three months or more
ceases to be protective in nature. Chronic pain has been found to negatively
affect activities of daily living and could limit activities such as social life, chores,
and work. The process of pain perception begins with the physiological process
of nociception via specialized pain receptors. These nociceptors transfer
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sensory information up the spinal cord through the peripheral nervous system to
the central nervous system and various neural pathways. Moreover, research
has shown that these various neural pathways can be activated by non-noxious
stimuli, suggesting that some psychological processes may influence pain
perception.
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Chapter III
Biopsychosocial Model of Pain
Biomedical models of pain assume that recovery from pain/injury occurrs
after tissue damage has been resolved (Gatchel et al., 2007). However, many
studies have demonstrated that some individuals may have no pain with organic
findings (Melzack & Katz, 2001), while other individuals with no organic findings
demonstrated disabling pain (Melzack, 1989). These individual differences in the
pain perception, recovery, and general pain experience stem from complex
interactions of biopsychosocial processes (Gatchel et al., 2007). These complex
interactions include a multitude of psychosocial factors that increase or decrease
individual recovery time. For instance, pain perception and disability can be
influenced by cognitive, emotional, and social factors as well as the ability to
cope with any complications related to the injury or recovery from the injury
(Hawker et al., 2010; Lerman, Rudich, Brill, Shalev & Shahar 2015; Tran et al.,
2015).
Psychosocial factors
Depression, anger, and anxiety have all been found to be interconnected with
chronic pain (Amtmann et al., 2015; Kroenke et al., 2011; Sagheer, Khan, &
Sharif, 2013). Studies have shown that these psychological emotions have an
important role in the pain experience, including, making an individual inclined to
11

experience pain, be a cause of pain symptoms, modulate the severity of the pain
experience (amplify or inhibit), be a consequence of chronic or persistent pain, or
perpetuate the pain experience (Asmundson et al., 2015). Numerous studies
have found that those experiencing chronic pain are at risk of experiencing
higher levels of anxiety and depression as well (Lerman et al., 2015; Sagheer et
al., 2013). In fact, chronic pain patients are at greater risk of developing severe
psychopathologies (e.g. paranoia, major depressive disorder) (Dersh, Gatchel,
Polatin, & Mayer, 2002).
The positive relationship between chronic pain and psychological distress
could be related to chronic pain being considered a chronic stressor. The
primary basis of stress response in any organism is correcting homeostatic
imbalance (Weissman, 1990). In other words, pain could be considered an
actual or perceived threat to an organism that disrupts normal functioning, which
results in the activation of mechanisms that serve to motivate the restoration of
basic functioning to normal levels (i.e. homeostatic imbalance; Weissman, 1990).
Chronic pain produces a multitude of events that can facilitate homeostatic
imbalance (stress) even after the actual damage has been resolved or in the
absence of any organic pathology (Weissman, 1990). This prolonged condition
of stress can have strong negative effects on the body and could cause a
mutually reinforcing relationship between pain and stress response (Basbaumet
al., 2009; Basbaum & Woolf, 1999; Burkey, 2014; Dafny, 1997).
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In the brain, for instance, pain related stress can cause the hypothalamus
to activate the pituitary gland that secretes adrenocorticotropic hormone, which
causes the adrenal cortex to secrete cortisol (Weissman, 1990). Cortisol
elevates blood sugar and increases metabolism, which allows for motivation of
resources to counteract the perceived or real threat and restore balance to the
system (Weissman, 1990). Prolonged activation of this system caused by
chronic pain could have serious negative effects on an individual including
muscle atrophy, suppression of immune system, alterations of brain structures,
and impairment of tissue repair and growth (Weissman, 1990). Concurrently,
body system changes could serve as priming mechanisms for the development
and/or maintenance of chronic pain, and in turn, alter an individual’s cognitions
and behaviors creating a negative feedback loop between actual and perceived
nociceptive threat (Basbaum et al., 2009; Basbaum & Woolf, 1999).
The relationship between chronic pain and psychological distress is
exemplified by studies that have looked at the chronic pain/depression
comorbidity. These studies have suggested that 40% - 50% of all chronic pain
sufferers also suffer from depressive symptoms, but in most cases, the
epidemiological nature of the relationship between chronic pain and depression
is still misunderstood (Asmundson et al., 2015). The direction of this relationship
is still unclear. Some studies have revealed that depression can cause chronic
pain or that chronic pain causes depression, while other studies have shown that
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they exist within a mutually reinforcing relationship (Asmundson et al., 2015). In
a recent meta-analysis, Burke, Mathias, and Denson (2015) found that
depression was the most commonly assessed psychological dimension within
chronic pain literature. Researchers also found moderate to very large effect
sizes for depression scores of those who had chronic pain. These scores were
also consistently statistically significant and negative indicating that those whose
suffer from chronic pain also had high levels of depression in comparison to
those who did not have chronic pain.
In another study, Kroenke et al. (2011) examined the relationship between
chronic pain and depression in a 12-month longitudinal study with 500 primary
care patients who had persistent back, hip, or knee pain, and were also enrolled
in the Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP)
study. Half of the participants were diagnosed with comorbid depression and the
other half were non-depressed with similar pain reports. Participants with
persistent pain and comorbid depression were randomized to a stepped care
intervention (n =123) or a treatment as usual condition (n = 127) while nondepressed patients were followed in parallel cohort. Researchers assessed
outcome measures at baseline, three, six, and twelve months and used mixed
effects model repeated measures (MMRM) multivariable analysis to determine if
change in pain severity predicted depression severity and vice versa. Results
revealed that change in depression was a strong predictor of pain severity and
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change in pain was an equally strong predictor of depression severity. Authors
concluded that pain and depression have equally strong effects on each other
when assessed longitudinally.
A longitudinal study by Hawker et al. (2010) examined whether
osteoarthritis (OA) pain determined depressed mood considering fatigue and
disability and found that chronic pain predicted future fatigue and disability, which
in turn predicted depressed mood. However, researchers also found that
depressed mood and fatigue were so interrelated that each exacerbated the
other, and fatigue and disability led to worsening of chronic pain. Depressed
mood seemed to indirectly affect severity of chronic pain, which could be said to
increase the likelihood of future disability and fatigue. It would seem then, that
the comorbidity between chronic pain and depression is a dynamic process that
leads to the worsening of functional outcomes for the individual (Hawker et al.,
2010)
Chronic Pain and Anxiety
Conceptually, anxiety is a future-oriented emotional state in response to
an elusive threat with an unclear source (Leeuw et al., 2006). Anxiety is often
associated with preventative and/or hyper-vigilant behavior, which may be
adaptive in short-term contexts, but is often counterproductive in the long run
(Asmundson et al., 2015; Leeuw et al., 2006). In chronic pain specifically, the
threat (pain) is constantly present, which in turn causes a never-ending cycle of
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anxiety response and preventative behaviors to avoid pain altogether
(Asmundson et al., 2015). The long-term consequences of this cycle could be
disability and disuse, which could lower the threshold at which later pain would
be experienced. Numerous studies have found high levels of anxiety in chronic
pain sufferers, and evidence that it does have an effect of functional outcomes of
the individual (Asmundson et al., 2015; Leeuw et al., 2006).
Sagheer et al. (2013) conducted a study to examine the prevalence of
anxiety depression in chronic low back pain patients at a tertiary care center. A
total of 140 chronic low back pain patients completed demographic
questionnaires and The Hospital Anxiety and Depression Scale (HADS).
Researchers found abnormal levels of anxiety in 77 (55%) patients and
borderline abnormal levels for anxiety in 54 (38.5%) of patients. Authors also
found significant gender differences for levels of anxiety within their sample with
20 (14.28%) males and 57 (40.71%) females reporting abnormal levels. Sagheer
et al. (2013) concluded that individuals with chronic low back pain were at high
risk for anxiety and the risk was significantly higher for females.
Amtmann et al. (2015) examined the mediational effects of anxiety,
fatigue, and sleep on the relationship between chronic pain and depression in
1,245 participants with multiple sclerosis (MS). Researchers used crosssectional self-report symptoms, quality of life data and structural equation
modeling to examine the variance in depression stemming from various pain-
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related factors (anxiety, sleep, fatigue). Authors discovered an adequately fitting
model of the indirect effects of pain on depression, which accounted for
approximately 80% of variance in depression. Researchers concluded that
higher pain was also associated with greater fatigue, anxiety, and sleep
disturbance, which in turn was associated higher levels of depression.
Essentially, high levels of chronic pain, indirect effects of that pain (anxiety), and
depression were all linked within this study’s sample. Considering these findings,
anxiety could have acted as a possible mediator between chronic pain and
depression.
In another study, Lerman et al. (2015) examined the longitudinal
relationship between pain, pain-related disability, and symptoms of anxiety in 428
individuals with chronic pain receiving treatment at a specialty pain clinic.
Participants completed questionnaires relating to their pain, state anxiety, and
pain-related disability at four time points with a mean of 5 months between each
point. Researchers used cross-lagged, structural equation modeling to examine
longitudinal associations between the variables. More than half of the sample
reported significant symptoms of anxiety (T1-69%, T2-68%, T3-75%, and T473%) at each of the four measurement points and half of the sample reported
significant symptoms of both anxiety and pain-related disability at each
measurement (T1-45%, T2-45%, T3-47%, and T4-48%). Researchers also
found that a latent anxiety variable predicted pain and pain related disability, but
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neither pain nor pain-related disability predicted anxiety. Authors concluded that
in adult chronic pain patients, high levels of anxiety may exacerbate pain and
pain-related disability.
Tran et al. (2015) examined whether anxiety and pain catastrophizing
were distinct from each other in relation to functional outcomes in pediatric pain,
and if they distinctly predict functional outcomes based on age. In a sample of
725 children and adolescents, researchers measured pain characteristics,
anxiety, pain catastrophizing, functional disability, and health-related quality of
life (HRQOL). Using structural equation modeling, authors found that anxiety
and pain catastrophizing were distinct in their sample. Additionally, anxiety
predicted HRQOL in children and adolescents, and functional disability in
adolescents alone. Based on these findings, fearful personalities could influence
the way individuals perceive threat as exemplified by a painful stimulus.
Fear of Pain
Fear is the emotional reaction to an immediate, identifiable threat, such as
a dangerous situation or an injury (Leeuw et al., 2006). Like anxiety, fear is an
adaptive response that serves to protect from harm by activating the fight or flight
response (Leeuw et al., 2006). The three crucial components of fear (perception
of a stimulus as threatening, increased arousal, and defensive behavior) are
connected and can fluctuate at different rates (Leeuw et al., 2006). The fear
response, specifically defensive escape behaviors, may alleviate fear in the short
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term, but may also negatively reinforce fear-related behaviors in the future
(Leeuw et al., 2006). Abnormally high levels of fear occurring more often may
lead to a lowered threshold for defensive escape behaviors, which in turn may
lead to a greater chance of pain related anxiety (Leeuw et al., 2006).
In relation to fear, the way perceived threat (i.e. pain stimulus) is
interpreted may lead to two distinct outcomes (Vlaeyen & Linton, 2000). When
the pain is perceived as non-threatening (low levels of fear), individuals are more
likely to maintain regular levels of daily activity, which promotes functional
recovery (Vlaeyen & Linton, 2000). This concept was supported by the findings
of Vowles and Gross (2003), who found that decreased levels of fear-avoidance
beliefs for work was an important factor for improving physical capability and
enhanced return to work potential. However, when pain is interpreted as
threatening (high levels of fear), typically the case with chronic pain, it could give
rise to pain-related defensive escape behaviors such as avoidance (Vlaeyen &
Linton, 2000). Asmundson and Norton (1995) supported this relationship by
revealing that chronic back pain patients with high anxiety sensitivity reported
greater levels of fear of pain and had greater avoidance of activities in
comparison to those with lower anxiety sensitivity, despite both groups having
equal pain.
Keogh, Ellery, Hunt, and Hannet (2001) examined whether fear of pain
would be related to greater selective attentional bias in favor of pain-related
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stimuli by exposing participants to varied stimuli in terms of being pain-related,
socially threatening, or positive. Researchers found that those with high levels of
fear of pain displayed a selective attentional bias towards pain-related stimuli
compared to those who had lower levels of fear of pain. Researchers concluded
that these results provide evidence for high levels of fear of pain biasing
attentional processes, which in turn may make individuals more susceptible to
negative experiences with pain. In other words, Keogh et al. (2001) suggested
that higher levels of fear of pain can bias one’s attention towards pain related
information, priming them to react negatively to any further pain-related
stimulation.
Peters, Vlaeyen, and Weber (2005) investigated the contribution of
physical pathology, pain-related fear, and catastrophizing cognitions to pain
intensity and disability in 100 participants with low back pain. Participants
completed self-report measures and quantified physical pathology via medical
charts using the MEDICS procedure. It was found that pain-related fear
accounted for 10% of variance in regression models for pain intensity and
disability. This means that fear of pain was an important predictor of pain
intensity. Researchers concluded that fear of pain could lead to a preoccupation
with pain and a heightened awareness of pain signals, which in turn could lead to
increased pain perception.
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Woby, Watson, Roach, and Urmston (2004) found similar results. In their
study, 83 chronic pain participants completed a series of self-report measures
before they participated in a physical therapist led intervention. Regression
analysis indicated that fear-avoidance beliefs about work and physical activity
were independently associated with levels of disability. In further analyses,
researchers found that fear-avoidance beliefs about physical activity were the
only statistically significant predictor of participants’ levels of disability. These
results indicated that those participants who endorsed greater levels of fearavoidance beliefs specifically about physical activity tended to report greater
levels of disability. Therefore, fear of pain is positively associated greater levels
of disability (Peters et al., 2005; Woby et al., 2004).
De Gier, Peters, and Vlaeyen (2003) examined the role of pain related
fear and attentional processes on tolerance for physical activity in 81 fibromyalgia
participants. Researchers had high and low fearful fibromyalgia participants
perform a physical task, a cognitive (reaction) task, and a dual task that
combined both physical and cognitive components. Results revealed that low
fearful participants demonstrated higher activity tolerance for both single and
dual conditions. It was also found that high fearful participants responded slower
on cognitive reaction time than low fearful participants. Researchers indicated
that level of pain-related fear did not significantly affect toleration for physical
performance task, but it was trending in that direction. In another more recent
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study, Niederstrasser et al. (2015) found that pain-related fear affected physical
perception of pain in 82 healthy university students. Researchers exposed
participants to an experimental muscle injury protocol designed to induce pain in
targeted body regions (left or right arm) and their respective muscle group and
asked them to complete self-report fear of pain measures. A day after being
exposed to this procedure, participants were asked to rate their pain while they
lifted weighted canisters with both the targeted and non-targeted body regions.
Niederstrasser et al. (2015) indicated that the experimental pain protocol
was effective at producing pain, which was indicated by increased pain report for
the targeted arm during session two. Although the non-targeted arm was
unaffected by the pain inducing protocol, pain report for the non-targeted arm
increased during the canister lift in session two across all lifts at a significantly
greater rate compared to session one. That is to say, that an inherently nonnoxious stimulus produced higher levels of verbally reported pain in the nontargeted arm. Researchers postulated that interactions between pain report and
levels of pain-related fear, which were only present during session 2, predicted
increased pain report. Interestingly, participants with high and low levels of fear
reported similar levels of pain during the first session, but only those with higher
levels of fear reported increased pain in the non-targeted arm.
Vowles and Gross (2003) also found interesting results in relation to painrelated fear, fear-avoidance behaviors, and changes in physical capability in their
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study. In this study, 65 participants with chronic pain complete an
interdisciplinary functional restoration program and collected pre- and posttreatment measures of fear-avoidance beliefs (FABQ – Waddell, Newton,
Henderson, Somerville, & Main, 1993), short form McGill pain questionnaire
(MPQ-SF; Melzack, 1987), and measures of physical ability for work. Results
indicated significant decreases in fear-avoidance beliefs, decreases in pain
severity, and increased ability for work at post-treatment. A secondary aspect of
the study was to examine the validity of measures of fear-avoidance in the
prediction of actual physical capability for work. Results revealed that changes in
fear-avoidance beliefs for work had a meaningful relation to changes in capability
for work. These findings suggest that changing fear-avoidance beliefs for work
was an important factor for improving physical capability and enhanced return to
work potential.
Based on the above findings, fear of pain could have an important effect
on the cognition and behavior of those who are suffering from pain. These
results could be due to that fear of pain can bias attentional processes in favor of
pain-related stimuli, which could result in greater number of negative experiences
with pain (Keogh et al., 2001). Fear of pain could also influence avoidance
related behaviors, which could lead to greater disability (Peters et al., 2005,
Woby et al., 2004). Furthermore, changes in pain-related fear and fearavoidance beliefs seemed necessary for increased physical capability and work
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potential (Vowles & Gross, 2003). Therefore, it is crucial to identify interventions
that can contribute to decreasing this detrimental emotional state in individuals
with pain.
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Chapter IV
Neurofeedback
QEEG
EEG is the measure of electrical changes within one or more of the cortical
regions of the brain via electrodes placed on the scalp (Cannon, 2015;
Hammond, 2011; Kaiser, 2007). The Electrodes are placed on specific sites
according to an International 10-20 system, which divides the skull into
proportional sections in relation to distinguishable landmarks: dent of the nose,
protrusion in the back of the head, and preauricular points directly in front of each
ear (Cannon, 2015; Hammond, 2011; Kaiser, 2007). For a visual representation
of the International 10-20 system, see Figure 2.
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Figure 2. The international 10-20 system.
Each electrode bears a particular label that corresponds to underlying brain
areas: F for frontal, FP for frontal pole, P for parietal, C for central, T for temporal,
and O for occipital (Cannon, 2015; Hammond, 2011; Kaiser, 2007). Sites are
sequenced numerically from the midline (Z), with odd number on the left
hemisphere and even numbers on the right hemisphere (Cannon, 2015;
Hammond, 2011; Kaiser, 2007). Electrical activity is identified as a difference in
potential between two electrodes in a grounded system (Cannon, 2015;
Hammond, 2011; Kaiser, 2007). This difference in potential can be measured in
reference to another electrode, usually along the midline (Cz) or a linked ear (A1
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or A2), this is often referred to as referential recording (Cannon, 2015;
Hammond, 2011; Kaiser, 2007). Recordings can also be completed in a bipolar
manner where electrodes are paired together with no common reference (i.e.,
site F4 is linked to C4; C4 to P4, P4 to O2) (Cannon, 2015; Hammond, 2011;
Kaiser, 2007).
The electrical activity or rhythm produced by the brain falls within
conventional frequency bands measured in cycles per second or hertz (Hz)
(Cannon, 2015; Hammond, 2011; Kaiser, 2007). Generally, each frequency
band has been associated with a particular mental state, such as, Delta activity
(0.5-3.5Hz), associated with deep sleep (Hammond, 2011); Theta activity (4-8
Hz), associated with a very relaxed state, sometimes referred to as the twilight
zone between waking and sleep; Alpha activity (8-12 Hz), associated with a
relaxed, disengaged state; Sensorimotor rhythm activity (13-15 Hz), associated
with a relaxed attentive state; Beta activity (13-30 Hz), associated with
intellectual activity and outward focus; and Gamma activity (30+ Hz), associated
with intense focus, attention, and with processes that involve multiple brain
networks communicating with each other (Cannon, 2015; Hammond, 2011;
Kaiser, 2007). It is important to note, that varying degrees of each of these
brainwave frequencies have been found to occur simultaneously in different parts
of the brain for most individuals (Cannon, 2015; Hammond, 2011; Kaiser, 2007).
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In general, dominant brainwave patterns are an indication of awareness level
(what is NF) (Cannon, 2015; Hammond, 2011; Kaiser, 2007).
Quantitative EEG (QEEG) is the sophisticated processing of EEG
recordings that quantifies the electrical activity gathered from electrodes, which
can be used to provide numerical values that represent patterns of activity
occurring in the brain (Kaiser, 2007). QEEG takes raw brain activity and uses
mathematical processing to quantify and compare that activity to a large
normative database of EEG activity (Kaiser, 2007). QEEG produces standard
scores for an individual’s brain activity based on the activity of others with the
same age and gender (Kaiser, 2007). This process allows for comparison of
brain activity based on a normative sample (i.e., others that are similar in age
and gender) (Kaiser, 2007). It also allows for comparisons of brain activity within
the same individual (Kaiser, 2007). A clinician/therapist could complete a QEEG
assessment at one point and then again at a later point in order to compare the
scores and ascertain the magnitude and direction of any changes in brain activity
(Kaiser, 2007).
Neurofeedback Therapy
Neurofeedback Therapy (NFT) is just audio and/or visual feedback based
on QEEG or brainwave activity (Cannon, 2015; Hammond, 2011). The process
for NFT closely resembles the process for gathering EEG or QEEG data, but with
the addition of providing feedback to the individual whose brainwave activity is
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being measured (Cannon, 2015; Hammond, 2011). In a typical training session,
one or more electrodes are placed on the scalp and the earlobes (Cannon, 2015;
Hammond, 2011). The electrodes measure electrical activity occurring at the
scalp and send this information to a computer program that records that data and
provides instantaneous audio or visual feedback about EEG activity to the
individual being trained (Cannon, 2015; Hammond, 2011).
Typically, participants would not be able to willfully influence their
brainwave activity because they are not consciously aware of their activity level
(Cannon, 2015; Hammond, 2011). However, when participants see or hear a
representation of their brainwave activity occurring in real-time, it allows them to
gradually change that activity (Cannon, 2015; Hammond, 2011). Conceptually,
this closely relates to operant conditioning, where participants recondition and
retrain their brainwave activity to match a predetermined criterion (Cannon, 2015;
Hammond, 2011). Once this criterion has been met, the participant receives
rewards in the form of audio and visual feedback (Cannon, 2015; Hammond,
2011). For instance, in one session, a typical participant may receive anywhere
from 300 to 1500 rewards depending on time-frame, participant variables
(attention, fatigue level etc.), and criterion difficulty level (Cannon, 2015;
Hammond, 2011).
Psychopathologies. Neurofeedback has been utilized in therapy for
various disorders with increasing empirical support of its effectiveness compared
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to other therapies and placebo. Researchers interested in comparing NFT to
medication in the treatment of ADD/ADHD have consistently found NFT to
produce comparable, sometimes superior, improvements in attention and
concentration compared to taking typical ADD/ADHD medication (Leins et al.,
2007; Rossiter & LaVaque, 1995). In one study, Rossiter and LaVaque (1995)
sought to examine the efficacy of 20 sessions of EEG biofeedback in reducing
ADHD symptoms and to compare the results with psychostimulant medication.
Researchers compared an EEG group with a matched (age, IQ, gender, and
diagnosis) stimulant group on the Test of Variables of Attention (TOVA) measure,
which was administered pre- and post-treatment. Results indicated that both
groups improved on TOVA measures of attention, impulsivity, information
processing, and variability but did not differ from each other on change scores.
Authors indicated that these findings support EEG biofeedback as an effective
alternative to stimulant medication for ADHD symptoms.
In another randomized controlled study, Leins et al. (2007) investigated
whether neurofeedback treatment lead to an improvement in cognition and
behavior in 38 participants with ADHD aged 8-13 years-old. The treatment
procedure involved three phases of 10 sessions each of Neurofeedback training
using one of two different protocols: positive and negative slow cortical potential
shifts (SCPs); suppress Theta (4-8 Hz) while increasing Beta (12-20 Hz).
Results revealed that both neurofeedback protocols produced improvements in
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cognition and behavior with effect sizes ranging from small (ES =.34) to large
(ES= 1.02) and six-month follow-up results that did not differ significantly from
end-of-treatment results. Both parents and teachers reported seeing significant
improvements as well. These findings support the idea that neurofeedback can
be used to make meaningful changes in cognition and behavior in a
developmental disability (ADHD) context. In fact, after a meta-analysis
conducted in 2009, researchers concluded that NFT had met criteria for being
classified as an efficacious and specific treatment for ADD/ADHD (Arns,
Heinrich, & Strehl, 2014).
Neurofeedback has been shown to be an effective treatment for
psychological distress. For instance, Choobforoushzadeh, Neshat-Doost,
Molavi, and Abedi (2015) evaluated the effectiveness of NFT in treating
depression and fatigue in 24 participants with multiple sclerosis (MS) in a
randomized control study. Participants were randomized into two groups,
neurofeedback (16 sessions of NFT) training or treatment as usual and evaluated
three times (baseline, end of treatment, and two-month follow-up) throughout the
study using the Fatigue Severity Scale and Depression subscale of the Hospital
Anxiety and Depression Scale. Using a repeated measures analysis of variance,
researchers found that NFT significantly decreased symptoms of depression and
fatigue compared to the treatment as usual condition, and effects were
maintained at two-month follow-up.
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In another study, Rice, Blanchard, and Purcell (1993) investigated the
effectiveness of NFT in 45 participants who had generalized anxiety disorder in
comparison to a waiting list control group. Participants were randomly assigned
to one of four different NFT protocols or a pseudo meditation control condition
and evaluated on STAI-Trait Anxiety and psychophysiological symptoms using
the Psychosomatic Symptom Checklist. Results revealed that all participants
who received NFT treatment showed significant reduction in anxiety and
psychophysiological symptoms in comparison to the wait-list, pseudo meditation
control group and that decreased self-report of anxiety was maintained at six
weeks follow-up.
Pain. Neurofeedback has also been used to treat pain conditions. In a
pilot study, Caro and Winter (2011) used NFT in their investigation of how it
would affect attention and somatic symptoms within a sample of fibromyalgia
syndrome (FMS) patients with attention problems, as indicated via continuous
performance test (CPT). Researchers measured pain, fatigue, psychological
distress, morning stiffness, and tenderness while having some participants
complete 40 or more NFT sessions and having another control group who
received standard medical only. Those trained with NFT improved their visual,
but not auditory, attention on CPT measures and also showed improvement in
tenderness, pain, and fatigue. Although it was not significant, results also
revealed a trend toward improved psychological distress and morning stiffness,
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but only after forty or more session of NFT. Based on these findings, it seems
that NFT could be an effective therapy option for those suffering from chronic
pain as seen in patients with FMS.
In another study, Kayıran, Dursun, Dursun, Ermutlu, and Karamürsel
(2010) used a randomized, rater blind study to assess the efficacy of NFT in 36
participants with FMS. Researchers randomly divided participants into two
groups: one group received twenty sessions of NFT (four weeks) and another
received 10 mg per day of escitalopram (control) for eight weeks. All participants
received visual analogue scales for pain and fatigue, Hamilton and Beck
Depression and Anxiety Inventory Scales, Fibromyalgia Impact Questionnaire
and Short Form 36 as outcome measures. Results showed improvements on all
measures for both groups, but the NFT group showed greater benefits than
controls (p < .05). These findings indicate that NFT training had comparable and
even superior benefits compared to Selective Serotonin Reuptake Inhibitor
(SSRI) treatment, which is typically used in FMS patients to help with mood and
fatigue.
Jensen, Grierson, Tracy-Smith, Bacigalupi, and Othmer (2007) conducted
a study evaluating the effects of NFT on pain in participants with chronic pain.
Researchers sought to determine the average decrease in pain, identify the
percentage of pain decreases that were clinically meaningful, and document
other benefits of NFT training in a sample of 18 individuals with Complex
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Regional Pain Syndrome Type 1 (CRPS-I). Participants were given 0-10
numerical rating scale measures for pain intensity and other symptoms before
and after a 30 minute NFT training session. Researchers also performed a
series of t-tests to determine the significance of any changes, as well as,
computed effect sizes and percent change in order to quantify observed
improvements in symptoms. Results revealed substantial and significant
decrease in pain intensity with half of the participants reporting changes that
were clinically meaningful. Researchers concluded that many patients who
receive NFT training report short-term reductions in pain-related symptoms, but
long-term effects of NFT training for chronic pain requires further research to
evaluate its effectiveness as a treatment option.
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Chapter V
Rationale
Chronic pain is an increasingly prevalent and costly condition and this
trend will continue upward with the ever-increasing average age of America’s
population. Individual differences in pain perception, recovery, and general pain
experience stem from complex interactions of biopsychosocial processes. The
biological aspect of pain perception concludes with the brain analyzing and
interpreting pain related information that comes from nociceptors in the
peripheral nervous system. This pain related information is interpreted in the
brain in the context of the individual’s current cognitive and affective state and his
or her environmental surroundings.
Pain perception becomes a subjective experience, which is dictated
entirely by individual differences within the biopsychosocial processes. Research
has shown that chronic pain is strongly associated with psychological
components such as: depression, anxiety, stress, and pain-related fear. These
psychological aspects of chronic pain interact within the individual to produce
greater negative functional outcomes and greater chances of disability.
Therefore, it is important to identify interventions that can help reduce the
psychological distress that is associated with pain.
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Scientific advances in QEEG technology have made it possible for
individuals to be aware of their brain activity occurring in real-time. Using
Neurofeedback therapy, researchers have found that individuals can change
their brainwave activity in a therapeutic way. Neurofeedback has been shown to
work in various psychological disorders, as well as with chronic pain and pain
related symptoms. Unfortunately, there are no studies that have looked at the
effects of Neurofeedback therapy on fear of pain.
Purpose
The purpose of this study was to examine how Neurofeedback may affect
an element of pain, specifically fear of pain. In specific, this study sought to
examine if a single training session on specific neurofeedback protocols had an
effect on avoidant behavior and interfered with the relationship between
subjective fear (as measured by scores on the Fear of Pain Questionnaire – III;
FPQ – III) and physiological fear-avoidance behaviors in relation to pain-related
stimuli (measured via the Tobii X-260 eye-tracker).
Hypotheses
I.

Participants in the control group that have high scores on the FPQ-III will
exhibit more fear-avoidant behaviors as indicated by less and/or shorter
fixations within pain-related area of interest.
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II.

Individuals trained on neurofeedback targeting Right Hemisphere pain
pathways will have decreased fear-avoidant visual behaviors when
compared to Left-Hemisphere protocols and Controls.
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CHAPTER VI
Methods
Participants
The data for the current study was collected from 121 male and female
undergraduate students studying at a Southwestern University in the United
States with a final sample of 99 participants. Participants were screened on
arrival using a multi-item personal and family history wellness questionnaire that
covered injury, traumatic brain injury (TBI), multiple conditions known to cause
persisting pain (carpel tunnel syndrome, recurrent migraines, recurrent back pain
etc.) prescription drug use, and existing psychiatric and developmental disorders.
Recruitment for the study was accomplished through an online recruitment
program used by the university, Sona-Systems. The study was approved by the
Institutional Review Board (IRB). Participants were excluded if they had a history
of seizure or epilepsy (N=3), lack of NF training (N=6), or were missing eyetracking data (N=13). Final sample was 99 participants.
Materials & Equipment
FPQ-III. Fear of pain was determined using a 30-item self-report measure
developed by McNeil and Rainwater, (1998). The FPQ-III contains short
sentences describing painful experiences that participants rate on a five-point (15) Likert-type scale. Participants were asked to rate the degree of fear they
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anticipate experiencing related to the painful event. Higher scores indicate
greater fear and lower scoreindicate less fear of pain. The measure consists of
ten-item subscales including fears of severe pain, minor pain, and medical pain.
PCS. The Pain Catastrophization Scale (PCS) measures the level of
catastrophic thinking in relation to pain experience with catastrophizing defined
as “an exaggerated negative mental set brought to bear during actual or
anticipated painful experience” (Sullivan et al., 1995; Sullivan et al., 2001). Pain
Catastrophization as measured by the PCS consists of three main factors.
These factors are threat magnification, rumination, and learned helplessness.
The Cronbach alpha index for the total PCS was .93 when measured using a
sample of 288 college students at a Midwestern university (Osman et al., 1997).
Researchers measuring reliability across of the magnification subscale on the
PCS across three studies showed an average of Cronbach’s alpha .74 for
females, and .71 for males (Osman et al., 1997).
ASRS v1.1. The Adult ADHD Self-Report Scale Symptom Checklist
Version 1.1 (ASRS v1.1) was used to assess for ADHD symptomology. The
ASRS v1.1. consists of eighteen items assessing the ADHD DSM-IV-TR criteria.
Critical items are the core of the ASRS v1.1 Screener. The ASRS v1.1 Screener
also twelve supplemental questions that align with ADHD symptomatology. The
ASRS v1.1 is a 5 point Likert Scale ranging from Never to Very Often. The
ASRS has been shown to be valid and reliable within the adolescent and adult
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populations. Specifically, Adler et al. (2006) found a high internal consistency
between the items with a Cronbach a of 0.93 at time 1 and 0.94 at time 2 of the
study. Within the adult population, the ASRS was also found to have high
internal consistency for patient and rater-administered versions of the scale
(Cronbach’s a 0.88 for patient self-report and 0.89 for rater-administered).
Neurofeedback. EEG NFT training was carried out using the using the
BrainAvatar software and a 19-channel signal amplifier, Discovery 24E from
Brain Master Technologies, Inc. Brain Avatar is a single platform that allows for
patient assessment and training to be blended with EEG (Proler & Bass, 2012).
EEG data was recorded from four electrodes placed (F3, F4, C3, P4) on the skull
(10/20 system), with ground and reference electrodes placed on the earlobe.
Neurofeedback training is achieved by displaying participant’s real-time brain
activity to teach self-regulation of brain function. Brain activity is presented to the
participants in the form of a visual and auditory stimulus. For this study, this
feedback was quantified to determine capacity to train (i.e., Beeps Total).
Tobii X-260 eye-tracker. Eye tracking was performed using the Tobii X260 eye-tracker (see http://www.tobii.se/). The Tobii X-260 eye-tacker allowed
for the mapping of eye movements to various features on the screen during task
performance. It is a state of the art eye-tracking device that tracks the eyemovement of participants in real time and gives data on maintenance of gaze on
a single location. Areas of interest (AOIs) were generated by a JavaScript
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application. This application provided the screen coordinates for each element
that was of interest for a given image (i.e., pain-related stimuli vs. non-painrelated stimuli; please see appendix A for examples of these stimuli with outlined
area of interest). For the purpose of this study, fear-avoidant visual behavior was
defined as the difference between pain-related and non-pain-related stimuli on
eye-tracking measures. Relevant Eye tracking variables examined were Time to
First Fixation (TFF), First Fixation Duration (FFD), Total Fixation Duration (TFD),
Fixation Count (FC), and Visit Count (VC).
Eye-Tracking variables Operational Definitions.
•

TFF is length of time in milliseconds until the participants eye
fixates on a particular point within an AOI;

•

FFD is defined as the length of time in milliseconds that a fixation
lasts;

•

TFD is defined as the sum of the duration for all fixations within an
AOI;

•

FC is the quantified as the number of fixations (i.e. maintaining of
the visual gaze on a single location for 50-600 ms) within an AOI;

•

VC is defined as the number of visits (i.e. time interval between first
fixation on active AOI and end of last fixation within same AOI)
within an AOI.
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Procedure
Consent, screening and subject preparation. Upon arrival, participants
were informed about the nature of the study and given the informed consent. If
they accepted participation, they completed prescreening questionnaires.
Subjects that reported an injury, drug abuse, any psychiatric disorder, current
pain, history of chronic pain, or seizures/epilepsy were asked to stop the
experiment without any penalties. Those participants that passed the
prescreening then completed FPQ-III, PCS, and the ASRS v1.1. After
completion of questionnaires, participants’ skull was prepared for Neurofeedback
training.
Training. Participants were randomly assigned to one of three
Neurofeedback groups, 1) the Right Hemisphere training protocol group, 2) the
Left Hemisphere training protocol, and 3) the Sham condition. The Right
Hemisphere protocol consisted of neurofeedback training on locations F4 (GO
12-15Hz; STOP 20Hz and up) and P4 (GO 4-12Hz; STOP 15Hz and up). The
Left Hemisphere protocol consisted of neurofeedback training on locations F3
(GO 15-20Hz; STOP 4-7Hz and 20Hz and up) and C3 (GO 4-12Hz; STOP 15Hz
and up). The Sham protocol consisted of no direct training; instead participants
watched a pre-recorded “sham” training session. Feedback was achieved by
showing the participant their own brain activity. Such information was presented
to the participants in the form of auditory and visual feedback (beeps).
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Regardless of the condition, each participant trained for 30 minutes and received
continuous auditory and visual reinforcement.
Pain-relevant visualization task. After training occurred, participants
completed the non-pain/pain visualization tasks on the Tobii eye-tracker for a
total of 5 minutes. The task was combination of looking at images, either nonpain-relevant or pain-relevant, and answering questions about those images
shortly afterwards. Participants were shown an initial set of 32 non-pain-relevant
images, each image shown for second. Participants were then shown another
group of 32 pain-relevant images followed by a series of ten questions about
details either seen or unseen in the images. This task was designed to measure
fear-avoidant behavior (eye movement) in relation to pain-related stimuli.
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CHAPTER VII
Results
Descriptive statistics for the full sample are presented. The total number
of participants in the final sample was n = 99. The final sample Mage = 19.34
years (SD = 2.04); with a minimum age of 18 and a maximum age of 33. The
sample was primarily Caucasian (58.6%, n = 58) followed by Hispanic (24.2%, n
= 24), African-American (14.1%, n = 14), and Asian/Other (3%, n = 3). In terms
of school classification, the sample was mostly Freshmen (58.6%, n = 58) and
Sophomores (19.2%, n = 19) followed by Juniors (12.1%, n = 12), and
Senior/Other (10.1%, n = 10). For gender, the sample had a majority of female
participants (68.7%, n = 68) followed by male participants (31.3%, n = 31).
Randomly assigned participants were distributed between the three experimental
conditions in relatively equal fashion with a slight majority being in the sham
condition (39.4%, n = 39) followed by left hemisphere condition (29.3%, n = 29),
and right hemisphere condition (31.3%, n = 31). Table 1 presents a summary of
demographic variables divided by participant condition.
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Table 1
Descriptive statistics for final sample divided by participant condition (N = 99)
Sham
Left Hemisphere
Right Hemisphere
Total
n (%)
n (%)
n (%)
n (%)
Gender
Female
27 (27.3)
20 (20.2)
21 (21.2)
68 (68.7)
Male
12 (12.0)
9 (9.0)
10 (10.0)
31 (31.3)
Classification
Freshmen
23 (23.2)
16 (16.2)
19 (19.2)
58 (58.6)
Sophomore
11 (11.1)
4 (4.0)
4 (4.0)
19 (19.2)
Junior
1 (1.0)
6 (6.1)
5 (5.1)
12 (12.1)
Senior
3 (3.0)
3 (3.0)
3 (3.0)
9 (9.1)
Other
1 (1.0)
-- --- -1 (1.0)
Ethnicity
Caucasian
22 (22.2)
18 (18.2)
18 (18.2)
58 (58.6)
Hispanic
13 (13.1)
3 (3.0)
8 (8.1)
24 (24.2)
African-American
3 (3.0)
7 (7.1)
4 (4.0)
14 (14.1)
Asian
1 (1.0)
-- --- -1 (1.0)
Other
-- -1 (1.0)
1 (1.0)
2 (2.0)
Note: % = percentage of final sample; n = frequency within sample; Sham = sham NF training
condition; Left Hemisphere = left hemisphere NF training condition; Right Hemisphere = right
hemisphere NF training Condition.
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Table 2 presents the frequency distribution for other possible confounds that
occurred in the sample. Frequencies are separated by variable as well as by
condition. Across all conditions, 19 participants indicated experiencing a
concussion at some point in their life with a slight minority (n = 3) occurring in the
right hemisphere condition. In terms of chronic pain (pain lasting longer and
three months), 7 participants indicated that they had experienced chronic pain in
their lifetime with a majority (n = 5) occurring in the left hemisphere condition.
Sixteen participants indicated that they had experienced recurrent back pain with
relatively equal distribution across conditions. For psychiatric diagnoses, 12
participants reported having a diagnosis with a slight majority (n = 6) occurring in
the sham condition. Eight participants reported having a developmental
diagnosis equally distributed across conditions. In terms of taking psychiatric
drugs during their lifetime, 13 participants reported doing so with a slight majority
(n = 6) occurring in the sham condition.
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Table 2
Frequency of Other Possible Confounds (N = 99)

Sham Training
n (%)

Left
Hemisphere
Training

Right
Hemisphere
Training

n (%)

n (%)

All Groups
n (%)

Concussion
No

31 (31.3)

21 (21.2)

28 (28.3)

80 (80.8)

Yes

8 (8.1)

8 (8.1)

3 (3.0)

19 (19.2)

No

38 (38.4)

24 (24.2)

30 (30.3)

92 (92.9)

Yes

1 (1.0)

5 (5.1)

1 (1.0)

7 (7.1)

No

33 (33.3)

23 (23.2)

27 (27.3)

83 (83.8)

Yes

6 (6.1)

6 (6.1)

4 (4.0)

16 (16.2)

No

33 (33.3)

27 (27.3)

27 (27.3)

87 (87.9)

Yes

6 (6.1)

2 (2.0)

4 (4.0)

12 (12.1)

No

36 (36.4)

26 (26.3)

29 (29.3)

91 (91.9)

Yes

3 (3.0)

3 (3.0)

2 (2.0)

8 (8.1)

No

33 (33.3)

26 (26.3)

27 (27.3)

86 (86.9)

Yes

6 (6.1)

3 (3.0)

4 (4.0)

13 (13.1)

Chronic Pain

Recurrent Back Pain

Psychiatric Diagnosis

Developmental
Diagnosis

Taking Psychiatric
Drugs

Note: % = percentage of final sample; n = frequency within sample; Sham = sham NF
training condition; Left Hemisphere = left hemisphere NF training condition; Right
Hemisphere = right hemisphere NF training Condition.
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A Chi-square analysis was conducted to determine if ethnicity,
classification, or gender differed across conditions. Results indicated that
conditions were very similar in all above demographics (X2(2) < 9.836, p > .28).
An ANOVA was conducted to determine if age, training, ADHD reported
symptoms, Pain Catastrophization scores, fear of pain scores (total, minor,
severe, and medical), or pain sensitivity were significantly different between the
groups. Table 3 shows no significant differences between groups in any
demographic, training, ADHD or fear of pain variables.
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Table 3
Summary of ANOVA for Differences in Demographic Variables per Condition
Variable

Sham Training

Left Hemisphere
Training
M
(SD)
19.17
(1.34)

Right Hemisphere
Training
M
(SD)
19.29
(2.12)

M
19.28

(SD)
(2.97)

F
.082

p
.922

-

-

1346.97

(154.15)

1332.00

(137.56)

.260*

.612

ADHD Critical

8.46

(3.97)

8.90

(3.03)

8.87

(3.82)

.156

.855

ADHD Total

28.26

(12.13)

28.72

(9.54)

28.61

(11.18)

.017

.983

PCS Total

12.26

(8.48)

14.62

(10.68)

11.71

(9.35)

.812

.447

Fear-of-Pain:
Total

84.51

(21.34)

82.90

(22.39)

82.68

(24.10)

.070

.932

Fear-of-Pain:
Minor

21.87

(8.80)

21.66

(8.38)

20.90

(8.24)

.118

.889

Fear-of-Pain:
Severe

34.49

(8.44)

34.59

(9.12)

35.16

(8.88)

.056

.945

Fear-of-Pain:
Medical

28.13

(8.59)

26.69

(8.78)

26.71

(10.02)

.290

.749

Age
Beeps Total

Note: * T-test was conducted to determine differences in training rewards (Beeps Total) between
the left hemisphere training condition and the right hemisphere training condition. Age = mean
age of participants in each condition; Beeps Total = mean cumulative rewards (beeps) received
for participants in each condition; ADHD = Attention Deficit Hyperactivity Disorder; PCS = Pain
Catastrophization Scale; Fear-of-Pain = total and subscale scores on Fear-of-Pain Questionnaire
3; Sham = sham NF training condition; Left Hemisphere = left hemisphere NF training condition;
Right Hemisphere = right hemisphere NF training Condition.
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Table 4 displays correlations between potential covariates including ADHD
variables, PCS, FPQ-III scores (i.e., total scores, minor pain scores, severe pain
scores, and medical pain scores) and fear-avoidant eye behavior (e.g. TFF =
Time to first fixation; FFD = First fixation duration; TFD = Total fixation duration;
FC = Fixation count; VC = Visit count) during the pain and no-pain visual stimulus
for participants in the sham (control) condition only. This analysis was conducted
with the sham condition only because it was assumed that participants in this
group had zero-level of neurofeedback training. Results of the Pearson
correlation revealed the following: There were no significant correlations between
FFD and any other eye-tracking variables or other covariates. Time to first
fixation was significantly correlated with both FC and VC. Fixation count was
significantly correlated with VC and TFD. Total fixation duration was the only
eye-tracking variable that significantly correlated with other covariates,
specifically the FPQ-III subscale minor pain. No other eye-tracking variables
were significantly correlated with any other covariates (i.e., fear-of-pain, PCS, or
ADHD).
FPQ-III total scores were significantly correlated with all minor subscales
including minor pain, severe pain, and medical pain. Scores on the medical pain
subscale were also significantly correlated with minor pain subscale and severe
pain subscale score. In other covariates, PCS scores significantly correlated with
FPQ-III total score, minor pain subscale, severe pain subscale, and medical pain
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subscale as well as ADHD-related scores including critical scores, and total
scores. ADHD total scores significantly correlated with minor pain subscale
scores, and ADHD critical scores.
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Table 4
Correlation Matrix for Eye-tracking Variables, Fear of Pain Variables, and Other Covariates in the
Sham (Control) Minus Those Excluded from Group Analysis (N = 38)
2

3

4

5

6

7

8

9

10

11

12

Eye-tracking
1

TFF

.23

.24

-.28*

-.44**

.09

.09

.06

.08

.09

.05

.05

2

FFD

-

-.03

-.13

-.12

-.04

.01

-.05

-.05

.07

-.06

-.06

3

TFD

-

.45**

.06

-.05

-.24*

.03

.07

.06

.03

.11

4

FC

-

.55**

-.15

-.16

-.12

-.11

-.02

-.03

-.03

5

VC

-

-.06

-.17

.04

-.04

-.09

.00

.01

-

.80**

.88**

.88**

.37**

.07

.17

-

.53**

.54**

.32**

.17

.23*

-

.70**

.27**

.04

.09

-

.35**

.01

.14

-

.24*

.33**

-

.86**

FPQ-III
6

Total

7

Minor

8

Severe

9

Medical

PCS
10

Total

ADHD
11

Critical

12

Total

-

Note: TFF = Time to first fixation; FFD = First fixation duration; TFD = Total fixation duration; FC =
Fixation count; VC = Visit count. All eye-tracking variable scores are the estimated differences
between pain and no-pain images (e.g., TFF pain - TFF no-pain = TFF). Fear of pain = scores on
FPQ-III: Total = total score; Minor = score on minor pain subscale; Severe = score on severe pain
subscale; Medical = score on medical pain subscale. PCS = Pain Catastrophization Scale: Total
= total score. ADHD = scores on ASRS v1.1: Critical = sum of critical item scores; Total = total.
** = p < 0.01 (2-tailed); * = p< 0.05 (2-tailed).

52

A number of one-way ANOVAs were conducted to determine the effect of
training conditions (sham, left hemisphere training, and right hemisphere training)
on fear-avoidant eye behavior. Fear-avoidant eye behavior, again, was defined
as the difference between pain-related and non-pain-related stimuli (e.g., fixation
count on pain-related stimuli – fixation count on non-pain-related stimuli = fixation
count difference). Results of the ANOVA indicated significant differences for
training conditions on FFD difference and marginally significant differences on
total fixation duration difference. Post hoc comparisons using the Tukey HSD
test indicated that the mean first fixation duration difference for the right
hemisphere training condition was significantly greater than the left hemisphere
training condition. However, the sham condition did not significantly differ from
right hemisphere or left hemisphere training conditions (see Table 5).
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Table 5
Group Analysis of Variance for Effect Training Conditions on Fear-avoidant Eye Behavior
Differences
Sham

Left
Hemisphere
Training

Right
Hemisphere
Training

N = 39

N = 29

N = 31

M (SD)

M (SD)

M (SD)

F

P

Left

Right

TFF

0.13 (1.04)

0.16 (3.71)

-0.12 (3.92)

0.05

.944

.01

-.09

FFD

0.04 (0.28)

-0.05 (0.18)

0.13 (0.30)

3.37

.039

-.37

.31

TFD

6.57 (9.55)

11.80 (4.36)

9.28 (7.96)

3.07

.052

.67

.30

FC

12.28 (27.07)

18.82 (26.85)

11.64 (29.06)

0.60

.549

.24

-.05

VC

-3.00 (8.39)

-2.78 (9.15)

-5.79 (7.36)

1.17

.312

.03

-.35

Fear-Avoidant
Eye Behavior

Cohen’s d

Note: Cohen's d = Left and right hemisphere conditions compared to sham condition; All eyetracking variables represent differences in those measures on pain vs non-pain related stimuli
(e.g., TFFpain – TFFnon-pain = TFF); Sham = sham NF training condition; Left Hemisphere = left
hemisphere NF training condition; Right Hemisphere = right hemisphere NF training Condition.
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CHAPTER IV
Discussion
The purpose of this study was to determine if one session of neurofeedback
(NF) could affect a subjective pain experience and visual behavior. In specific,
this study looked to determine if 30 minutes of hemisphere-specific NF training
significantly decreased fear-of-pain related avoidant behavior measured via eyetracking.
Relationship between Fear of Pain and Eye-Tracking Variables
This study found a significant negative correlation between an FPQ-III
subscale (i.e., minor pain), and the eye-tracking variable total fixation duration
when participants were looking at pain-related pictures. This fear-of-pain and
eye-tracking correlation finding, suggests that selective attentional biases
towards pain-related stimuli (Keogh et al. 2001) can be measured via eyetracking (Bannerman, Milders, & Sahraie, 2010a, 2010b). This finding is
supported by Asmundson and Norton (1995) who found that chronic pain
patients reporting greater levels of fear-of-pain also displayed greater avoidance
than those with lower levels of fear, even after controlling for perceived level of
pain. This finding is also supported by De Gier et al. (2003) who found that
participants with high pain-related fear differed significantly from their low fear
counterparts by demonstrating slower reaction times on a cognitive task.
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However, eye-tracking in this sample, did not correlate with report of fear of
medical injuries. Considering that our sample is composed of healthy young
adults, it is possible that participants in the current sample have not been
exposed to medical conditions that lead to severe pain, and thus, they are less
avoidant of such images. This conclusion is supported by early fear acquisition
models which suggest that previous experiences are crucial for establishing and
maintaining future fear-related behavior (Mineka & Cook, 1986; Muris,
Steerneman, Merckelbach, & Meesters, 1996; Rachman, 1977; Rachman, 1991).
NF training effects on Fixation Duration and Time to First Fixation
Contrary to what we expected, group analyses revealed that those individuals
who received Left-Hemisphere NF training had longer Total Fixation Duration
within pain-related areas of interest than those who received Sham training,
although results are at the level of approaching statistical significance (p<=.052).
Effect size for the comparison Left Hemisphere NF training and Sham were
considerate moderate (d = .67) suggesting possible effects of NF on fearavoidance eye-behavior.
The current study found significant group differences on first fixation duration
when looking at pain-related pictures. Specifically, those trained on Right
Hemisphere NF training protocols held their first visual gaze on a single location
longer than those trained on Left Hemisphere NF training protocols.
Interpretation of this finding is difficult given that this eye-tracking measure did
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not significantly correlate with any measure on the FPQ-III or the ADHD-related
measure. It is possible that this finding may reflect an unaccounted-for variable
within the study such as novelty (i.e., new pain-related features in the second set
of images), curiosity (i.e., differences in the second set of images lead to
increased fixations), or other visual perception factors. However, this is still not
clear, and future studies are needed to test these possibilities.
Interpretation of Results
Our findings seem to support studies that have suggested NF training as a
neuromodulation technique for reducing the fear of pain in clinical settings. In
specific, Jensen et al. (2007) found clinically meaningful decreases in pain
intensity at primary pain sites for 18 spinal cord injury participants. Researchers
found statistically significant improvement on measures of psychological wellbeing. Despite the lack of connection between some fear-of-pain, ADHD-related
symptoms, and eye-tracking behavior, it is possible that NF training protocols,
specifically right hemisphere specific protocols influenced attention-related brain
networks in such a way that resulted in longer first fixation durations within painrelated stimuli (Gevensleben et. al, 2009a; Gevensleben et. al, 2009b).
Studies using similar to our NF training protocols, have found evidence of
significant improvements in attention-related behavior measures in individuals
diagnosed with ADHD have (Gevensleben et. al, 2009a; Gevensleben et. al,
2009b). Specifically, Gevensleben et. al (2009a) found that the improvement for
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combined NF training group were superior to the placebo group with moderate
effect sizes (ES = .60). Effects sizes for NF training on attention-related
processes, such as the approach explained above, have been reportedly
comparable to effect sizes reported for pharmacological treatments
(methylphenidate; ES NF = 0.81 vs. ES methylphenidate = 0.84). These findings
seem to indicate that NF training protocols targeting specific attention-related
neural networks result in significant improvements in attentional processes.
Limitations and Future Studies
Eye-tracking behavior as measured in the current study failed to
significantly correlate with overall fear-of-pain scores, ADHD-related scores, and
scores on the PCS. As such, there is potentially no true relationship between
eye-tracking measures and behavioral outcome measures in the current study.
With this initial assumption of relationship not being met, it is difficult to make
definitive conclusions about the meaning of performance on eye-tracking
measures in relation to the manipulated variable (i.e., NF training). Future
studies should aim to establish connections between measures of eye-tracking
(e.g., first fixation duration, total fixation duration, and fixation count) and other
behavioral outcome measures before testing assumed effects on eye-tracking
measures. These established relationships could serve as the foundations of
future predictions about eye-tracking and behavior in response to manipulation of
independent variables.
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The current study made use of a convenient sample of healthy college
students which could result in generalizability issues (i.e., any conclusions made
are in reference to sample itself and not greater population), under
representation of sociodemographic differences (misrepresentation of ethnic
minorities), and introduce modest amounts of variability within groups resulting in
unpredictable results and inconsistent findings (Bornstein, Jager, & Putnick,
2013). This modest variability could have translated to increased variability
within conditions in the current study resulting in inconsistencies in statistical
significance and effect sizes (Bornstein et al., 2013). Future studies could aim to
decrease within group variability by focusing on a specific target population such
as those individuals suffering from persistent chronic pain or any other unique
population.
In collecting data for the current study, many participants (n = 22) were
excluded for various reasons including issues with technology, poor effort, and/or
history of mental or physical health concerns. Future studies should aim to refine
data collection procedures using technology such as eye-tracking software to
decrease the likelihood of lost participant data due to technological difficulties.
Finally, it is typical for participants to be exposed to multiple NF sessions.
In the current study, participants were exposed to just one training session which
may have translated into smaller effect sizes overall. Future studies should
examine the cost and benefits of exposing participants to multiple sessions of NF
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training as a way of ensuring that the appropriate level of effect is achieved in
order to compare to other similar NF training studies.
Conclusion
In the current study, it was found that FPQ-III subscale (minor pain) scores
were negatively correlated with total fixation duration when participants were
looking at pain-related pictures suggesting that higher levels of fear of minor pain
may be associated with attentional biases towards pain-related stimuli. However,
other eye-tracking variables measured in the current study showed no significant
correlations with FPQ-III total scores and medical or severe pain subscale
scores. Previous research indicates that these suggested attentional biases may
be influenced by prior experience which could explain findings in the current
study.
Analyses revealed group differences approaching significance for the
individuals who received Left-Hemisphere NF training compared to those who
received Sham training for total fixation duration. Although not significant, effect
sizes for this for comparison were considered moderate. There were significant
group differences found between those trained on Right-Hemisphere NF
protocols compared to those who received Left-Hemisphere NF training on first
fixation duration. However, this finding is difficult to interpret given that first
fixation duration did not significantly correlate with any FPQ-III measures, ADHDrelated measure, or the PCS measure. Overall, findings from the current study
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provide some support for previous research implicating NF training as a
neuromodulation technique for affecting the subjective pain experience.
Neurofeedback could potentially be useful to decrease the psychological
outcome often related to chronic pain. Validation of this beneficial therapeutic
approach for chronic pain and related symptoms requires further scrutiny.
Specific variables related to its effectiveness including behavioral correlates with
pain-related fear should be examined more closely to determine their relationship
to the experience of pain and how specific NF training protocols may affect them.
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